Cancer diagnosis, treatment and follow-up care.
4 companies · 2 products
Clinical genomics software that analyses next-generation sequencing data for rare disease and cancer diagnostics in laboratories, with a variant-prioritisation model it calls DiagAI.
Genomics · Based in France
Developer of DERM, an AI medical device that assesses dermoscopic images of skin lesions referred on the urgent suspected skin cancer pathway.
Clinical AI · Based in United Kingdom
Genomic data analysis platform used by hospitals and laboratories to interpret sequencing results.
Genomics · Based in Switzerland
Laboratory genomic analysis platform for oncology, inherited and infectious disease, with the DiagAI variant-prioritisation model; IVDR Class C certified by GMED, according to the company.
GenomicsWebGenomic analysis platform that calls, annotates and pre-classifies variants from sequencing data for clinical teams.
GenomicsWebAPI
